Immunogenicity of a DNA vaccine candidate for COVID-19
…, KY Kim, TA Herring, S Reeder, VM Andrade… - Nature …, 2020 - nature.com
The coronavirus family member, SARS-CoV-2 has been identified as the causal agent for
the pandemic viral pneumonia disease, COVID-19. At this time, no vaccine is available to …
the pandemic viral pneumonia disease, COVID-19. At this time, no vaccine is available to …
[HTML][HTML] Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
…, A Patel, A Christensen-Quick, VM Andrade… - …, 2021 - thelancet.com
Background A vaccine against SARS-CoV-2 is of high urgency. Here the safety and
immunogenicity induced by a DNA vaccine (INO-4800) targeting the full length spike antigen of …
immunogenicity induced by a DNA vaccine (INO-4800) targeting the full length spike antigen of …
Intradermal-delivered DNA vaccine provides anamnestic protection in a rhesus macaque SARS-CoV-2 challenge model
…, J Choi, A Generotti, J Harrison, NJ Tursi, VM Andrade… - BioRxiv, 2020 - biorxiv.org
Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, has had a dramatic
global impact on public health, social, and economic infrastructures. Here, we assess …
global impact on public health, social, and economic infrastructures. Here, we assess …
DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2
…, J Cui, N Chokkalingam, NJ Tursi, VM Andrade… - Nature …, 2022 - nature.com
Monoclonal antibody therapy has played an important role against SARS-CoV-2. Strategies
to deliver functional, antibody-based therapeutics with improved in vivo durability are …
to deliver functional, antibody-based therapeutics with improved in vivo durability are …
INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants
VM Andrade, A Christensen-Quick, J Agnes, J Tur… - npj Vaccines, 2021 - nature.com
Global surveillance has identified emerging SARS-CoV-2 variants of concern (VOC)
associated with broadened host specificity, pathogenicity, and immune evasion to vaccine-induced …
associated with broadened host specificity, pathogenicity, and immune evasion to vaccine-induced …
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in …
…, M Purwar, A Christensen-Quick, N Liu, VM Andrade… - MedRxiv, 2021 - medrxiv.org
Background Vaccines against SARS-CoV-2 are still urgently needed as only 5% of the global
population has been vaccinated. Here we report the safety and immunogenicity of a DNA …
population has been vaccinated. Here we report the safety and immunogenicity of a DNA …
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption
VM Andrade, C Mavian, D Babic… - Proceedings of the …, 2020 - National Acad Sciences
HIV-1 persists in cellular reservoirs that can reignite viremia if antiretroviral therapy (ART) is
interrupted. Therefore, insight into the nature of those reservoirs may be revealed from the …
interrupted. Therefore, insight into the nature of those reservoirs may be revealed from the …
SARS-CoV-2 DNA vaccine INO-4800 induces durable immune responses capable of being boosted in a phase 1 open-label trial
…, N Liu, VM Andrade… - The Journal of …, 2022 - academic.oup.com
Background Additional severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccines that are safe and effective as primary vaccines and boosters remain urgently needed …
vaccines that are safe and effective as primary vaccines and boosters remain urgently needed …
[PDF][PDF] Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model
…, A Generotti, J Harrison, NJ Tursi, VM Andrade… - Cell Reports …, 2021 - cell.com
Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, has had a dramatic
global impact on public health and social and economic infrastructures. Here, we assess …
global impact on public health and social and economic infrastructures. Here, we assess …
[PDF][PDF] Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines may target epitopes
that reduce durability or increase the potential for escape from vaccine-induced immunity. …
that reduce durability or increase the potential for escape from vaccine-induced immunity. …
